These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20138190)

  • 21. Flumazenil: US clinical pharmacology studies.
    Dunton AW; Schwam E; Pitman V; McGrath J; Hendler J; Siegel J
    Eur J Anaesthesiol Suppl; 1988; 2():81-95. PubMed ID: 2842144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit.
    DeCarolis DD; Rice KL; Ho L; Willenbring ML; Cassaro S
    Pharmacotherapy; 2007 Apr; 27(4):510-8. PubMed ID: 17381377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation between the cognitive process and the phenomenological experience of TOT: effect of the anxiolytic drug lorazepam on TOT states.
    Bacon E; Schwartz BL; Paire-Ficout L; Izaute M
    Conscious Cogn; 2007 Jun; 16(2):360-73. PubMed ID: 16798012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological manipulations of arousal and memory for emotional material: effects of a single dose of methylphenidate or lorazepam.
    Brignell CM; Rosenthal J; Curran HV
    J Psychopharmacol; 2007 Sep; 21(7):673-83. PubMed ID: 17606475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Information processing and benzodiazepines.
    Kleindienst-Vanderbeke G
    Neuropsychobiology; 1984; 12(4):238-43. PubMed ID: 6535067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different effects of lorazepam and diazepam on perceptual integration.
    Beckers T; Wagemans J; Boucart M; Giersch A
    Vision Res; 2001 Aug; 41(17):2297-303. PubMed ID: 11448721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the amnesic effects of lorazepam in alcoholics and non-alcoholics.
    Mallick JL; Kirkby KC; Martin F; Philp M; Hennessy MJ
    Psychopharmacology (Berl); 1993; 110(1-2):181-6. PubMed ID: 7870881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychopharmacological analysis of implicit and explicit memory: a study with lorazepam and the benzodiazepine antagonist flumazenil.
    Bishop KI; Curran HV
    Psychopharmacology (Berl); 1995 Sep; 121(2):267-78. PubMed ID: 8545533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose oral lorazepam administration in Alzheimer subjects and age-matched controls.
    Sunderland T; Weingartner H; Cohen RM; Tariot PN; Newhouse PA; Thompson KE; Lawlor BA; Mueller EA
    Psychopharmacology (Berl); 1989; 99(1):129-33. PubMed ID: 2506598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of benzodiazepine on temporal integration in object perception.
    Boucart M; de Visme P; Wagemans J
    Psychopharmacology (Berl); 2000 Oct; 152(3):249-55. PubMed ID: 11105934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline plasma GABA: its relationship to the adverse effects of acute lorazepam administration on cognition in the elderly.
    Pomara N; Willoughby LM; Sidtis JJ; Doraiswamy PM; Wesnes KA; Cooper TB; Greenblatt DJ
    Neurochem Res; 2004 Dec; 29(12):2311-5. PubMed ID: 15672555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic predictors of benzodiazepine response trajectory in anxiety disorders: a Bayesian hierarchical modeling meta-analysis.
    Stimpfl JN; Mills JA; Strawn JR
    CNS Spectr; 2023 Feb; 28(1):53-60. PubMed ID: 34593077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the sedative and amnestic effects of chlorpromazine and lorazepam.
    Green JF; McElholm A; King DJ
    Psychopharmacology (Berl); 1996 Nov; 128(1):67-73. PubMed ID: 8944408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam.
    Gupta SK; Ellinwood EH; Nikaido AM; Heatherly DG
    J Pharmacokinet Biopharm; 1990 Apr; 18(2):89-102. PubMed ID: 2348383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of lorazepam on perceptual integration of visual forms in healthy volunteers.
    Giersch A; Boucart M; Danion JM; Vidailhet P; Legrand F
    Psychopharmacology (Berl); 1995 May; 119(1):105-14. PubMed ID: 7675941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lorazepam pharmacodynamics and pharmacokinetics in children.
    Relling MV; Mulhern RK; Dodge RK; Johnson D; Pieper JA; Rivera GK; Evans WE
    J Pediatr; 1989 Apr; 114(4 Pt 1):641-6. PubMed ID: 2926577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of lorazepam on prosaccades and saccadic adaptation.
    Bey K; Lippold JV; Aslan B; Hurlemann R; Ettinger U
    J Psychopharmacol; 2021 Jan; 35(1):91-99. PubMed ID: 33274663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.
    Colburn WA; Jack ML
    Clin Pharmacokinet; 1987 Sep; 13(3):179-90. PubMed ID: 2822333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzodiazepine impairment of perirhinal cortical plasticity and recognition memory.
    Wan H; Warburton EC; Zhu XO; Koder TJ; Park Y; Aggleton JP; Cho K; Bashir ZI; Brown MW
    Eur J Neurosci; 2004 Oct; 20(8):2214-24. PubMed ID: 15450101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some facilitatory effects of lorazepam on dynamic visual binding.
    Elliott MA; Giersch A; Seifert D
    Psychopharmacology (Berl); 2006 Jan; 184(2):229-38. PubMed ID: 16374601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.